Abstract

<p>Machine learning in cardiovascular disease has broad applications in healthcare, automatically identifying hidden patterns in vast data without human intervention. Early-stage cardiovascular illness can benefit from machine learning models in drug selection. The integration of granular computing, specifically z-numbers, with machine learning algorithms, is suggested for cardiovascular disease identification. Granular computing enables handling unpredictable and imprecise situations, akin to human cognitive abilities. Machine learning algorithms such as Naïve Bayes, K-Nearest Neighbor (KNN), Random Forest, and Gradient Boosting are commonly used in constructing these models. Experimental findings indicate that incorporating granular computing into machine learning models enhances the ability to represent uncertainty and improves accuracy in cardiovascular disease detection.</p>

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.